Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy

Phase

N/A

Condition

N/A

Treatment

Educational Intervention

Health Promotion and Care

Questionnaire Administration

Clinical Study ID

NCT06541158

STUDY00007528

NCI-2024-05756

P30CA138292

WINSHIP6207-24

Ages > 18
All Genders

Study Summary

This clinical trial evaluates whether the Transportation for Cancer Care Navigation Tool (TRACT) can reduce travel barriers among patients with solid tumors receiving radiation therapy. It is estimated that 20-30% patients with cancer experience travel-related barriers for cancer care. This is a particular problem for patients with radiation therapy as these patients frequently receive multiple treatment cycles, which often require daily treatment for multiple weeks or months. Addressing travel barriers has been a prerequisite for cancer care as travel barriers negatively influence cancer treatment adherence and cancer care outcomes, such as survival and quality of life. The TRACT program may help reduce travel barriers and therefore promote health equity among patients with solid tumors receiving radiation therapy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Age ≥ 18 years
Diagnosed with solid tumors
Undergoing RT (not excluded with chemotherapy)
Competent to give consent
English-speaking
With travel barriers as screened by the reliable and validated 10-itemTransportation Barriers Measure. In this study, item 2 ("how much trouble is it foryou to get transportation to your doctor or treatment?") from the general barriersdomain will be used to screen patients for travel barriers

Exclusion

Exclusion Criteria:

Receive palliative care
Are non-English-speaking (excluded due to pilot data without fund to supporttranslation services)
Are enrolled in lodging programs (e.g., the American Cancer Society [ACS] HopeLodge®)
Have major depression/anxiety disorders that interfere with their ability toparticipate (based on the electronic medical records report)

Study Design

Educational Intervention

November 06, 2024

February 28, 2027

Study Description

PRIMARY OBJECTIVES:

I. To work collaboratively with a Community Advisory Board (CAB, e.g., patients, caregivers, clinicians, and social workers) to refine a theory-driven TRACT program for solid tumor patients receiving radiation therapy (RT) with travel barriers.

II. To evaluate the feasibility of the TRACT program for patients with solid tumors receiving RT with travel barriers.

III. To explore the efficacy of the TRACT program on RT adherence (canceling, delaying, missing, or terminating essential care) and patient-reported outcomes (PROs) (distress, financial toxicity, and quality of life [QOL]) compared to enhanced usual care (EUC, usual care + transportation awareness brief video with Patient Advocate Foundation [PAF] pamphlet).

OUTLINE:

STAGE I (CAB): Participants meet with the study research team to develop and refine the TRACT program.

STAGE II: Patients are randomized to 2 groups.

GROUP I: Patients receive the TRACT program consisting: of 1) Screening of travel barriers; 2) Awareness of transportation obstacles and resources using videos, 3) Assistance with transportation resource application and utilization, and 4) Alignment of community resources to navigate individualized transportation support by the trained travel navigator for 3 months.

GROUP II: Patients receive usual care with PAF pamphlet for 3 months.

After completion of study intervention, patients are followed up at 3 months.

Connect with a study center

Emory Proton Therapy Center
Atlanta, Georgia 30308
United States
Site Not Available
Emory Saint Joseph's Hospital
Atlanta, Georgia 30342
United States
Active - Recruiting
Emory University Hospital Midtown
Atlanta, Georgia 30308
United States
Active - Recruiting
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia 30322
United States
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.